Literature DB >> 21319882

mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration.

Richard M Cleva1, Megan P Hicks, Justin T Gass, Kelly C Wischerath, Elizabeth T Plasters, John J Widholm, M Foster Olive.   

Abstract

Extinction of classically and instrumentally conditioned behaviors, such as conditioned fear and drug-seeking behavior, is a process of active learning, and recent studies indicate that potentiation of glutamatergic transmission facilitates extinction learning. In this study, the authors investigated the effects of the Type-5 metabotropic glutamate receptors (mGluR5) positive allosteric modulator 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) on the extinction of cocaine-seeking behavior in rats with a history of intravenous cocaine self-administration. To assess its effects on acquisition and consolidation of extinction learning, CDPPB (60 mg/kg) or vehicle was administered either 20 min prior to, or immediately following, each of 10 extinction sessions, respectively. When administered prior to each extinction session, CDPPB produced a significant reduction in the number of active lever presses on all 10 days of extinction training as compared to vehicle-treated animals. When administered following each extinction session, a significant reduction in the number of active lever presses was observed on the 2nd through 10th day of extinction. Both treatment regimens also reduced the number of extinction-training sessions required to meet extinction criteria. Pre- or postextinction-training administration of CDPPB did not alter responding on the inactive lever and had no effects on open field locomotor activity. These data indicate that positive allosteric modulation of mGluR5 receptors facilitates the acquisition and consolidation of extinction learning following cocaine self-administration and may provide a novel pharmacological approach to enhancing extinction learning when combined with cue exposure therapy for the treatment of cocaine addiction. (PsycINFO Database Record (c) 2011 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21319882      PMCID: PMC3073132          DOI: 10.1037/a0022339

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  62 in total

Review 1.  A learning theory perspective on lapse, relapse, and the maintenance of behavior change.

Authors:  M E Bouton
Journal:  Health Psychol       Date:  2000-01       Impact factor: 4.267

2.  Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

Authors:  H Awad; G W Hubert; Y Smith; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 3.  Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus.

Authors:  Eishichi Miyamoto
Journal:  J Pharmacol Sci       Date:  2006       Impact factor: 3.337

4.  Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

5.  Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.

Authors:  A Pisani; P Gubellini; P Bonsi; F Conquet; B Picconi; D Centonze; G Bernardi; P Calabresi
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

6.  Extracellular fluctuations of dopamine and glutamate in the nucleus accumbens core and shell associated with lever-pressing during cocaine self-administration, extinction, and yoked cocaine administration.

Authors:  Nobuyoshi Suto; Laurel E Ecke; Zhi-Bing You; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2010-06-12       Impact factor: 4.530

7.  Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator.

Authors:  Holger Rosenbrock; Gert Kramer; Scott Hobson; Eliza Koros; Marc Grundl; Matthias Grauert; Klaus G Reymann; Ulrich H Schröder
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

8.  A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models.

Authors:  Gene G Kinney; Julie A O'Brien; Wei Lemaire; Maryann Burno; Denise J Bickel; Michelle K Clements; Tsing-Bau Chen; David D Wisnoski; Craig W Lindsley; Philip R Tiller; Sheri Smith; Marlene A Jacobson; Cyrille Sur; Mark E Duggan; Douglas J Pettibone; P Jeffrey Conn; David L Williams
Journal:  J Pharmacol Exp Ther       Date:  2004-12-17       Impact factor: 4.030

Review 9.  Glutamate receptors in extinction and extinction-based therapies for psychiatric illness.

Authors:  Karyn M Myers; William A Carlezon; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

10.  D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

View more
  43 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

Review 2.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

3.  Extinction of an instrumental response: a cognitive behavioral assay in Fmr1 knockout mice.

Authors:  M S Sidorov; D D Krueger; M Taylor; E Gisin; E K Osterweil; M F Bear
Journal:  Genes Brain Behav       Date:  2014-04-30       Impact factor: 3.449

4.  Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.

Authors:  Kathy Sengmany; Junaid Singh; Gregory D Stewart; P Jeffrey Conn; Arthur Christopoulos; Karen J Gregory
Journal:  Neuropharmacology       Date:  2016-07-05       Impact factor: 5.250

5.  The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats.

Authors:  John J Widholm; Justin T Gass; Richard M Cleva; M Foster Olive
Journal:  J Addict Res Ther       Date:  2011-12-24

Review 6.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

7.  The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators.

Authors:  Christina Gobin; Marek Schwendt
Journal:  Psychopharmacology (Berl)       Date:  2019-08-24       Impact factor: 4.530

Review 8.  Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction.

Authors:  Daniela Neuhofer; Peter Kalivas
Journal:  Neurobiol Learn Mem       Date:  2018-02-09       Impact factor: 2.877

9.  The role of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and extinction learning.

Authors:  Lori A Knackstedt; Heather L Trantham-Davidson; Marek Schwendt
Journal:  Addict Biol       Date:  2013-05-27       Impact factor: 4.280

Review 10.  Metabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging.

Authors:  Rajapillai L I Pillai; Dnyanesh N Tipre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-07       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.